Kiniksa Pharmaceuticals International (KNSA) Accounts Payables (2017 - 2026)
Kiniksa Pharmaceuticals International's (KNSA) quarterly Accounts Payables came in at $12.4 million in Q2 2026, up 38.5% YoY from $9.0 million in Q2 2025, and down 49.17% on a QoQ basis from $24.4 million in Q1 2026.
Kiniksa Pharmaceuticals International (KNSA) Accounts Payables (2017 - 2026) Analysis & Trends
Kiniksa Pharmaceuticals International (KNSA) has 10 years of Accounts Payables data on file, last reported at $12.4 million in Q2 2026.
- Quarterly Accounts Payables rose 38.5% year-over-year to $12.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $12.4 million (up 38.5% YoY) and the FY2025 annual result came in at $2.0 million, down 0.54% from the prior year.
- Accounts Payables slipped to $12.4 million in Q2 2026, from $24.4 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $24.4 million in Q1 2026 to a low of $648000.0 in Q2 2023.
- A 5-year average of $5.9 million and a median of $4.5 million in 2022 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2024 — Accounts Payables slumped 75.27% — and 2026, when it surged 1131.18%.
- Tracing KNSA's Accounts Payables over 5 years: stood at $7.9 million in 2022, then advanced by 4.39% to $8.2 million in 2023, then tumbled by 75.27% to $2.0 million in 2024, then declined by 0.54% to $2.0 million in 2025, then surged by 511.64% to $12.4 million in 2026.
- The last three Accounts Payables figures came in at $12.4 million (Q2 2026), $24.4 million (Q1 2026), and $2.0 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 356.00 Mn |
| 10 | Kiniksa Pharmaceuticals International | 6.10 Bn | 5.58 Bn | 220.03 Mn | 12.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.40 Mn |
| Mar 31, 2026 | 24.40 Mn |
| Dec 31, 2025 | 2.03 Mn |
| Sep 30, 2025 | 6.15 Mn |
| Jun 30, 2025 | 8.96 Mn |
| Mar 31, 2025 | 1.98 Mn |
| Dec 31, 2024 | 2.04 Mn |
| Sep 30, 2024 | 8.33 Mn |
| Jun 30, 2024 | 7.39 Mn |
| Mar 31, 2024 | 5.63 Mn |
| Dec 31, 2023 | 8.25 Mn |
| Sep 30, 2023 | 1.01 Mn |
| Jun 30, 2023 | 648,000.00 |
| Mar 31, 2023 | 1.39 Mn |
| Dec 31, 2022 | 7.90 Mn |
| Sep 30, 2022 | 1.47 Mn |
| Jun 30, 2022 | 2.52 Mn |
| Mar 31, 2022 | 3.38 Mn |
| Dec 31, 2021 | 1.87 Mn |
| Sep 30, 2021 | 1.65 Mn |